TITLE

PHARMACOLOGY OF DRUGS USED IN THE CONTROL OF HYPERCHOLESTEROLEMIA

AUTHOR(S)
Moses, Campbell
PUB. DATE
February 1962
SOURCE
Angiology;Feb1962, Vol. 13 Issue 2, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the pharmacology of the drugs used in the control of hypercholesterolemia. Absorption of beta-sitosterol to a limited extent from the intestinal tract; Lowering of the total serum cholesterol through neomycin dosage; Depression of cholesterol levels in animal models by using uricosuric agent benzmalacene.
ACCESSION #
16371236

 

Related Articles

  • CEREBROVASCULAR ACCIDENT.  // Review of Optometry;3/15/2005 Supplement, Vol. 142, p52A 

    This article reports that the cerebrovascular accident (CVA), also known as stroke or "brain attack," represents a sudden, focal disruption in circulation to the brain, and results in a corresponding loss of neurologic function. Men demonstrate a higher incidence than women, and increasing age...

  • Ezetimibe/Simvastatin: A Review of its Use in the Management of Hypercholesterolemia. Murdoch, David; Scott, Lesley J. // American Journal of Cardiovascular Drugs;2004, Vol. 4 Issue 6, p405 

    Ezetimibe/simvastatin (Inegyâ„¢, Vytorinâ„¢) therapy combines two lipid-lowering compounds with complementary mechanisms of action, thereby blocking the two sources of plasma cholesterol and improving lipid profiles. Thus, intestinal absorption of dietary cholesterol and related...

  • Long-term effects of policosanol on obese patients with Type II Hypercholesterolemia. Mas, R.; Castaño, G.; Fernández, J.; Gamez, R.; Illnait, J.; Fernandez, L.; Lopez, E.; Mesa, M.; Alvarez, E.; Mendoza, S. // Asia Pacific Journal of Clinical Nutrition;2004 Supplement, Vol. 13, pS102 

    Both hypercholesterolemia (HC) and obesity are coronary risk factors. Clinical studies have shown the benefits of lowering elevated plasma levels of low-density lipoprotein-cholesterol (LDL-C) on clinical end-points. Policosanol is a cholesterol-lowering drug purified from sugar cane wax with a...

  • Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012. Mercado, Carla; DeSimone, Ariadne K.; Odom, Erika; Gillespie, Cathleen; Ayala, Carma; Loustalot, Fleetwood // MMWR: Morbidity & Mortality Weekly Report;12/4/2015, Vol. 64 Issue 47, p1305 

    A high blood level of low-density lipoprotein cholesterol (LDL-C) remains a major risk factor for atherosclerotic cardiovascular disease (ASCVD), although data from 2005 through 2012 has shown a decline in high cholesterol (total and LDL cholesterol) along with an increase in the use of...

  • Takayasu's Arteritis: A Hospital--Region Based Study on Occurrence, Treatment and Prognosis. Waern, A. Urban; Andersson, P.; Hemmingsson, A. // Angiology;May1983, Vol. 34 Issue 5, p311 

    Occurrence of Takayasu's arteritis (TA) is described in this work in a defined area of Sweden, namely the Uppsala Hospital region (1.3 million inhabitants). During the eight year period 1969-1976 there were 15 cases of TA discharged from the hospitals in this region. The estimated yearly...

  • ONE YEAR OF SODIUM DEXTROTHYROXINE THERAPY FOR HYPERCHOLESTEROLEMIA. Cohen, Burton M. // Angiology;Feb1962, Vol. 13 Issue 2, p69 

    Sodium dextrothyroxine, the sodium salt of the dextrorotatory isomer of thyroxine, was administered in daily oral doses ranging from 4 to 8 mg to 30 patients with hypercholesterolemic states for 52 weeks. A drop in serum cholesterol values was recorded in every patient, and averaged a reduction...

  • THYROID ANALOGS AS CHOLESTEROPENIC AGENTS. Hoff, H. Richard; Sperber, Robert J.; Fisch, Solomon; DeGraff, Arthur C. // Angiology;Feb1962, Vol. 13 Issue 2, p94 

    d-Triiodothyronine was administered to four patients in a double-blind multiple dose study. Although this drug was found to be a potent cholesteropenic agent, it possessed sufficient adverse calorigenic activity to make further study hazardous in patients with coronary atherosclerosis. Sodium...

  • Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Noakes, Manny; Clifton, Peter M.; Doornbos, Anne M. E.; Trautwein, Elke A. // European Journal of Nutrition;Jun2005, Vol. 44 Issue 4, p214 

    Background The cholesterol-lowering efficacy of plant sterol esters (PSteE) or stanol esters (PStaE) in regular- and low-fat spreads has been consistently demonstrated, while their effectiveness in a low-fat, aqueous food carrier such as milk and yoghurt is less well established. Aim of the...

  • Cholesterol controversy. Richardson, Vanessa // Self;Feb97, Vol. 19 Issue 2, p56 

    Discusses the controversy over the United States government's National Cholesterol Education Program guidelines calling for regular cholesterol checks beginning at age 20. Risk of overprescription of cholesterol-lowering statin drugs; Long-term effects of cholesterol-lowering drugs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics